Related Experiment Video

Updated: Aug 15, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapy

Parameshwar J Mahasreshti1, Manjula Kataram, Hongju Wu

  • 1Division of Human Gene Therapy, Department of Medicine, University of Alabama at Birmingham, AL 35294, USA. param@uab.edu

Gynecologic Oncology
|October 18, 2005
PubMed
Abstract

Insights

Enhanced adenoviral vectors targeting ovarian cancer show improved melanoma differentiation-associated gene-7 (mda-7) delivery and efficacy. These modified Ad.RGD.mda-7 and Ad.RGD.pK7.mda-7 viruses significantly increase tumor cell killing and prolong survival in mouse models.

Area of Science:

  • Oncolytic virotherapy
  • Gene therapy
  • Ovarian cancer research

Background:

  • Adenoviral-mediated melanoma differentiation-associated gene-7 (Ad.mda-7) therapy shows potential for ovarian cancer treatment.
  • Previous Ad.mda-7 therapy exhibited low apoptosis induction correlated with low infectivity.

Purpose of the Study:

  • To develop ovarian cancer-targeted, infectivity-enhanced adenoviral vectors encoding mda-7.
  • To evaluate the enhanced therapeutic efficacy of these modified vectors in ovarian carcinoma.

Main Methods:

  • Engineered Ad.RGD.mda-7 and Ad.RGD.pK7.mda-7 vectors by incorporating RGD and/or Pk7 motifs into fiber knobs.
  • Validated viral constructs for mda-7 presence and MDA-7 protein expression.
  • Assessed in vitro cell killing using crystal violet staining and in vivo therapeutic efficacy in ovarian cancer xenograft mouse models.

Main Results:

  • Both Ad.RGD.mda-7 and Ad.RGD.pK7.mda-7 demonstrated significantly increased ovarian cancer cell killing in vitro compared to Ad.mda-7.
  • Ad.RGD.pK7.mda-7 exhibited the highest level of in vitro cell killing.
  • Ad.RGD.pK7.mda-7 significantly improved survival rates in mice with human ovarian cancer xenografts.

Conclusions:

  • Infectivity-enhanced adenoviral vectors, specifically Ad.RGD.mda-7 and Ad.RGD.pK7.mda-7, significantly boost ovarian cancer cell death in vitro.
  • Ad.RGD.pK7.mda-7 shows substantial promise for clinical translation in ovarian cancer therapy due to prolonged survival in murine models.

More Related Videos

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...